+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Tuberculosis Testing Market by Test (Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing), End User (Hospital, Laboratories) - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985927
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Tuberculosis Testing Market size was estimated at USD 2.57 billion in 2023, USD 2.76 billion in 2024, and is expected to grow at a CAGR of 7.38% to reach USD 4.23 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tuberculosis Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tuberculosis Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tuberculosis Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Becton, Dickinson, and Company, bioMerieux SA, Bruker Corporation, Cepheid, Elisabeth Pharmacon, spol. s r.o., ELITech Group, F. Hoffmann-La Roche AG, Hologic Corporation, OSANG HEALTHCARE CO., LTD, PerkinElmer, Inc., Siemens AG, Thermo Fisher Scientific, Inc., and Türklab A.Ş.

Market Segmentation & Coverage

This research report categorizes the Tuberculosis Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Test
    • Culture Based Tests
    • Drug Susceptibility Testing
    • Nucleic Acid Testing
    • Radiography
    • Smear Microscopy
  • End User
    • Hospital
    • Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Tuberculosis Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tuberculosis Testing Market?
  3. What are the technology trends and regulatory frameworks in the Tuberculosis Testing Market?
  4. What is the market share of the leading vendors in the Tuberculosis Testing Market?
  5. Which modes and strategic moves are suitable for entering the Tuberculosis Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Tuberculosis Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of drug-resistant tuberculosis infection
5.1.1.2. Improvement in bacteriological confirmation
5.1.1.3. Increase in awareness enabling proper management of the disease
5.1.2. Restraints
5.1.2.1. Development of advanced and hybrid technique of multiple disorder detection
5.1.3. Opportunities
5.1.3.1. Rising demand for improved and technologically advanced tuberculosis testing procedures
5.1.3.2. Growing tuberculosis awareness and control programs
5.1.4. Challenges
5.1.4.1. Shortage of supply of TST antigens in various regions
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Tuberculosis Testing Market, by Test
6.1. Introduction
6.2. Culture Based Tests
6.3. Drug Susceptibility Testing
6.4. Nucleic Acid Testing
6.5. Radiography
6.6. Smear Microscopy
7. Tuberculosis Testing Market, by End User
7.1. Introduction
7.2. Hospital
7.3. Laboratories
8. Americas Tuberculosis Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Tuberculosis Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Tuberculosis Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. ACON Laboratories, Inc.
12.1.3. Becton, Dickinson, and Company
12.1.4. bioMerieux SA
12.1.5. Bruker Corporation
12.1.6. Cepheid
12.1.7. Elisabeth Pharmacon, spol. s r.o.
12.1.8. ELITech Group
12.1.9. F. Hoffmann-La Roche AG
12.1.10. Hologic Corporation
12.1.11. OSANG HEALTHCARE CO., LTD
12.1.12. PerkinElmer, Inc.
12.1.13. Siemens AG
12.1.14. Thermo Fisher Scientific, Inc.
12.1.15. Türklab A.S.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. TUBERCULOSIS TESTING MARKET RESEARCH PROCESS
FIGURE 2. TUBERCULOSIS TESTING MARKET SIZE, 2022 VS 2030
FIGURE 3. TUBERCULOSIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. TUBERCULOSIS TESTING MARKET DYNAMICS
FIGURE 7. TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2022 VS 2030 (%)
FIGURE 8. TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 10. TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. TUBERCULOSIS TESTING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. TUBERCULOSIS TESTING MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. TUBERCULOSIS TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. TUBERCULOSIS TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 6. TUBERCULOSIS TESTING MARKET SIZE, BY CULTURE BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TUBERCULOSIS TESTING MARKET SIZE, BY DRUG SUSCEPTIBILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TUBERCULOSIS TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TUBERCULOSIS TESTING MARKET SIZE, BY RADIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TUBERCULOSIS TESTING MARKET SIZE, BY SMEAR MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. TUBERCULOSIS TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. TUBERCULOSIS TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 22. CANADA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 24. MEXICO TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES TUBERCULOSIS TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 34. CHINA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. INDIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 36. INDIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. JAPAN TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 40. JAPAN TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. THAILAND TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 52. THAILAND TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 59. DENMARK TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. EGYPT TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 61. EGYPT TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. FINLAND TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 63. FINLAND TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 65. FRANCE TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 67. GERMANY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 71. ITALY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. NORWAY TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 77. NORWAY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. POLAND TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 79. POLAND TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. QATAR TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 81. QATAR TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 89. SPAIN TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. TURKEY TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 95. TURKEY TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM TUBERCULOSIS TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. TUBERCULOSIS TESTING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 101. TUBERCULOSIS TESTING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 102. TUBERCULOSIS TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Becton, Dickinson, and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cepheid
  • Elisabeth Pharmacon, spol. s r.o.
  • ELITech Group
  • F. Hoffmann-La Roche AG
  • Hologic Corporation
  • OSANG HEALTHCARE CO., LTD
  • PerkinElmer, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Türklab A.Ş.

Methodology

Loading
LOADING...

Table Information